Bronchiectasis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Bronchiectasis}}
{{Bronchiectasis}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}; {{AE}} {{HQ}}, Saarah T. Alkhairy, M.D.


==References==
==Overview==
Bronchiectasis is normally diagnosed after months or years of symptoms. Patients have [[respiratory]] complications, [[infection]], and [[hemoptysis]].  Death can be caused by [[cardiac]] and [[respiratory]] failure.  Bronchiectasis shows a higher [[mortality]] with males, advanced age, poor functional status, severe disease based on radiographic findings, and evidence of [[hypoxemia]] and [[hypercapnia]].
 
==Natural History==
*There is often a delay between the onset of symptoms and  diagnosis
*The classic symptoms are [[cough]], daily [[mucopurulent]] [[sputum]] production, and [[dyspnea]]
**These symptoms are usually present for months to years
**The symptoms are manifestations of the lung being repeatedly damaged due to any number of causes
 
*Over the years the patient can develop recurrent [[infections]], massive [[hemoptysis]], and [[ pulmonary hypertension]]


==Bronchiectasis Natural History, Complications, and Prognosis==
*In about 8-10 years, there is a high mortality  rate  due to [[cor pulmonale]] or [[respiratory failure]]


*Bronchiectasis has been shown to contribute to early mortality.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208  }} </ref>
==Complications==
**Factors associated with higher mortality were advanced age, poor functional status, more severe disease based on radiographic findings, and evidence of hypoxemia or hypercapnia.
*Recurrent [[infection]]
*Increased [[sputum]] production
*[[Dyspnea]]
*Massive [[hemoptysis]]
*[[Pulmonary hypertension]]
**Decreased air is traveling through the [[bronchus]]
**Less [[oxygen]] is being distributed everywhere
**Causes [[Lung|pulmonary]] constriction which increases the pulmonary pressure


*In US long-term cohort of 91 patients, 30% died during a 13-year follow-up period (median age 60 years).<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208  }} </ref>
*[[Cor pulmonale]]
*[[Respiratory failure]]


*Early mortality was associated with male sex.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208  }} </ref>
==Prognosis==
*Bronchiectasis has been shown to contribute to early [[mortality]]<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208  }} </ref>
*Early [[mortality]] is associated with
**Males<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208  }} </ref>
**Advanced age<ref>{{cite journal |author=Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G|title=Analysis of the factors related to mortality in patients with bronchiectasis. |language=English |journal= Respir Med. |volume=101 |issue=7 |pages=1390-97 |year=2007 |pmid=17374480 |doi=}}</ref>
**Poor functional status<ref>{{cite journal |author=Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G|title=Analysis of the factors related to mortality in patients with bronchiectasis. |language=English |journal= Respir Med. |volume=101 |issue=7 |pages=1390-97 |year=2007 |pmid=17374480 |doi=}}</ref>
**More severe disease based on radiographic findings<ref>{{cite journal |author=Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G|title=Analysis of the factors related to mortality in patients with bronchiectasis. |language=English |journal= Respir Med. |volume=101 |issue=7 |pages=1390-97 |year=2007 |pmid=17374480 |doi=}}</ref>
**Evidence of [[hypoxemia]] or [[hypercapnia]]<ref>{{cite journal |author=Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G|title=Analysis of the factors related to mortality in patients with bronchiectasis. |language=English |journal= Respir Med. |volume=101 |issue=7 |pages=1390-97 |year=2007 |pmid=17374480 |doi=}}</ref>  


*Bronchiectasis related to Pseudomonas aeruginosa, severe exacerbations, systemic inflammation are associated with disease progression
*Infected with ''[[Pseudomonas aeruginosa]]'', severe exacerbations, and systemic [[inflammation]] are associated with disease advancement
*10% of adults with bronchiectasis die within 5-8 years of diagnosis, majority with the cause of death being respiratory related
*Up to 10% of adults die within 5-8 years of diagnosis (majority being respiratory related)<ref>{{cite journal |author=Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G|title=Analysis of the factors related to mortality in patients with bronchiectasis. |language=English |journal= Respir Med. |volume=101 |issue=7 |pages=1390-97 |year=2007 |pmid=17374480 |doi=}}</ref>
*Good nutrition,ideal body weight, and regular vaccinations correlate with improved survival


==References==


{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Mature chapter]]
[[Category:Emergency medicine]]


​​​
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Pulmonology]]
[[Category:Medicine]]
[[Category:Up-To-Date]]

Latest revision as of 20:43, 29 July 2020

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis natural history, complications and prognosis

CDC on Bronchiectasis natural history, complications and prognosis

Bronchiectasis natural history, complications and prognosis in the news

Blogs on Bronchiectasis natural history, complications and prognosis

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2], Saarah T. Alkhairy, M.D.

Overview

Bronchiectasis is normally diagnosed after months or years of symptoms. Patients have respiratory complications, infection, and hemoptysis. Death can be caused by cardiac and respiratory failure. Bronchiectasis shows a higher mortality with males, advanced age, poor functional status, severe disease based on radiographic findings, and evidence of hypoxemia and hypercapnia.

Natural History

  • There is often a delay between the onset of symptoms and diagnosis
  • The classic symptoms are cough, daily mucopurulent sputum production, and dyspnea
    • These symptoms are usually present for months to years
    • The symptoms are manifestations of the lung being repeatedly damaged due to any number of causes

Complications

Prognosis

  • Infected with Pseudomonas aeruginosa, severe exacerbations, and systemic inflammation are associated with disease advancement
  • Up to 10% of adults die within 5-8 years of diagnosis (majority being respiratory related)[6]

References

  1. 1.0 1.1 McDonnell MJ, Ward C, Lordan JL, Rutherford RM (2013). "Non-cystic fibrosis bronchiectasis". QJM. 106 (8): 709–15. doi:10.1093/qjmed/hct109. PMID 23728208.
  2. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G (2007). "Analysis of the factors related to mortality in patients with bronchiectasis". Respir Med. 101 (7): 1390–97. PMID 17374480.
  3. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G (2007). "Analysis of the factors related to mortality in patients with bronchiectasis". Respir Med. 101 (7): 1390–97. PMID 17374480.
  4. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G (2007). "Analysis of the factors related to mortality in patients with bronchiectasis". Respir Med. 101 (7): 1390–97. PMID 17374480.
  5. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G (2007). "Analysis of the factors related to mortality in patients with bronchiectasis". Respir Med. 101 (7): 1390–97. PMID 17374480.
  6. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, Karabiyikoglu G (2007). "Analysis of the factors related to mortality in patients with bronchiectasis". Respir Med. 101 (7): 1390–97. PMID 17374480.

​​​ Template:WH Template:WS